T37.4X3A Poisoning by anthelminthics, assault, initial encounter

Name of the Condition

• Poisoning by anthelminthics, assault, initial encounter

Summary

This condition involves poisoning by anthelminthic medications resulting from an assault, with the initial encounter indicating the first time the patient is receiving care for this event. Anthelminthics are drugs used to treat parasitic worm infections, and poisoning in this context refers to toxic effects from exposure to these agents due to intentional harm by another party. The condition requires prompt medical evaluation and intervention to address acute toxicity and ensure patient safety.

Causes

Poisoning by anthelminthics in an assault scenario occurs when a patient is intentionally exposed to these medications by another individual. This may involve forced ingestion, administration, or exposure to the drugs with harmful intent. The assault-related nature distinguishes this from accidental or self-inflicted poisoning, focusing on external causation.

Risk Factors

• Proximity to individuals with access to anthelminthic medications.
• Situations involving conflict or violence where forced exposure is possible.
• Lack of supervision or control over medication storage in environments where assault risks exist.

Symptoms

• Gastrointestinal: Nausea, vomiting, abdominal pain, or diarrhea.
• Neurological: Dizziness, confusion, seizures, or altered mental status.
• Dermatological: Rash, itching, or hypersensitivity reactions.
• Systemic: Organ dysfunction (e.g., hepatic or renal) or metabolic disturbances.

Diagnosis

Clinical evaluation focuses on medication history, symptom onset, and confirmation of assault. Lab tests (e.g., drug levels, renal/hepatic function) may be used to assess toxicity. Documentation of the assault and initial encounter is critical for accurate coding and care coordination.

Treatment Options

Treatment addresses acute toxicity, including decontamination (if appropriate), supportive care (e.g., managing symptoms), and monitoring for organ dysfunction. Specific antidotes for anthelminthics are limited, so management is primarily symptomatic and supportive.

Prognosis and Follow-Up

Prognosis depends on the dose and type of anthelminthic, timing of intervention, and patient factors (e.g., organ function). Follow-up may involve monitoring for delayed effects and addressing any underlying trauma from the assault. Long-term care may be needed for complications or psychological support.

Complications

• Severe organ damage (e.g., hepatic or renal failure).
• Neurological sequelae (e.g., persistent confusion or seizures).
• Psychological trauma related to the assault.
• Delayed toxic effects from prolonged drug exposure.

Lifestyle & Prevention

Prevention focuses on safety measures to avoid exposure to harmful substances, especially in environments where assault risks are present. Secure storage of medications and awareness of surroundings may reduce risk, though assault-related poisoning is often unpredictable.

When to Seek Professional Help

Seek immediate medical attention if poisoning is suspected, particularly if symptoms like severe nausea, confusion, or organ dysfunction occur. Prompt care is critical to mitigate toxicity and address potential assault-related injuries.

Tips for Medical Coders

Use this code for initial encounters of poisoning by anthelminthics due to assault. Document the assault context and initial encounter clearly. Ensure differentiation from accidental or self-harm poisonings, as coding depends on intent and encounter timing.